Hepatitis B elimination in children of Slovenian origin born in Slovenia after the introduction of preventive strategies: The results of a national study
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
WHO. Global hepatitis report, 2017. Accessed March 7th, 2021 at: http://www.who.int/hepatitis/publications/global-hepatitis-report2017/en/WHOGlobal hepatitis report2017Accessed March 7th, 2021 athttp://www.who.int/hepatitis/publications/global-hepatitis-report2017/en/Search in Google Scholar
Locarnini S, Hatzakis A, Chen DS, Lok A. Strategies to control hepatitis B: public policy, epidemiology, vaccine and drugs. J Hepatol. 2015;62:S76-86. doi: 10.1016/j.jhep.2015.01.018.LocarniniSHatzakisAChenDSLokAStrategies to control hepatitis B: public policy, epidemiology, vaccine and drugsJ Hepatol201562S768610.1016/j.jhep.2015.01.018Open DOISearch in Google Scholar
Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global burden of disease study 2010. Lancet. 2012;380:2095-128. doi: 10.1016/S0140-6736(12)61728-0.LozanoRNaghaviMForemanKLimSShibuyaKAboyansVet alGlobal and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global burden of disease study 2010Lancet2012380209512810.1016/S0140-6736(12)61728-0Open DOISearch in Google Scholar
Schweitzer A, Horn J, Mikolajczyc RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386:1546-55. doi: 10.1016/S0140-6736(15)61412-X.SchweitzerAHornJMikolajczycRTKrauseGOttJJEstimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013Lancet201538615465510.1016/S0140-6736(15)61412-XOpen DOISearch in Google Scholar
Coalition for global hepatitis elimination. Accessed January 26th, 2022 at: https://www.globalhep.org/country-progress/SloveniaCoalition for global hepatitis eliminationAccessed January 26th2022https://www.globalhep.org/country-progress/SloveniaSearch in Google Scholar
Hahne JMS, Veldhuijzen IK, Wiessing L, Lim TA, Salminen M, Van de Laar M. Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening. BMC Infect Dis. 2013;13:181–226. doi: 10.1186/1471-2334-13-181.HahneJMSVeldhuijzenIKWiessingLLimTASalminenMVande Laar MInfection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screeningBMC Infect Dis20131318122610.1186/1471-2334-13-181371689223597411Open DOISearch in Google Scholar
WHO. Combating Hepatitis B and C to reach elimination by 2030. Accessed March 7th, 2021 at: http://apps.who.int/iris/bitstream/10665/206453/1/WHO_HIV_2016.04_eng.pdfWHO. Combating Hepatitis B and C to reach elimination by 2030Accessed March 7th, 2021 athttp://apps.who.int/iris/bitstream/10665/206453/1/WHO_HIV_2016.04_eng.pdfSearch in Google Scholar
Cox AL, El-Sayed MH, Kao JH, Lazarus JV, Lemoine M, Lok AS, et al. Progress towards elimination goals for viral hepatitis. Nat Rev Gastroenterol Hepatol. 2020;9:533-42. doi: 10.1038/s41575-020-0332-6.CoxALEl-SayedMHKaoJHLazarusJVLemoineMLokASet alProgress towards elimination goals for viral hepatitisNat Rev Gastroenterol Hepatol202095334210.1038/s41575-020-0332-6737631632704164Open DOISearch in Google Scholar
Hutin Y, Desai S, Bulterys M. Preventing hepatitis B virus infections: milestones and targets. Accessed March 7th, 2021 at: https://www.who.int/bulletin/volumes/96/7/18-215210/en/HutinYDesaiSBulterysMPreventing hepatitis B virus infections: milestones and targets. Accessed March 7th2021https://www.who.int/bulletin/volumes/96/7/18-215210/en/10.2471/BLT.18.215210602261929962544Search in Google Scholar
WHO. Hepatitis B vaccines: WHO position paper, July 2017 – Recommendations. Vaccine. 2019;37:223-5. doi: 10.1016/j.vaccine.2017.07.046.WHOHepatitis B vaccines: WHO position paper, July 2017 – RecommendationsVaccine201937223510.1016/j.vaccine.2017.07.04628743487Open DOISearch in Google Scholar
WHO. Status of new vaccine introduction – worldwide, September 2016. Accessed March 7th, 2021 at: http://apps.who.int/iris/bitstream/10665/252768/1/WER9201.pdf?ua=1WHO. Status of new vaccine introduction – worldwide, September 2016Accessed March 7th, 2021 athttp://apps.who.int/iris/bitstream/10665/252768/1/WER9201.pdf?ua=1Search in Google Scholar
Wang S, Cohen C, Tang AS, Graham CS. Hepatitis B virus elimination in the U.S.: Time to dismantle barriers and implement solutions. Curr Hepatol Report. 2021;20:34-42. doi: https://doi.org/10.1007/s11901-020-00557-3WangSCohenCTangASGrahamCSHepatitis B virus elimination in the U.S.: Time to dismantle barriers and implement solutionsCurr Hepatol Report2021203442https://doi.org/10.1007/s11901-020-00557-310.1007/s11901-020-00557-3Search in Google Scholar
Pravilnik o določitvi Programa cepljenja in zaščite z zdravili za leto 2021. Accessed January 26 th, 2022 at: https://www.nijz.si/sites/www.nijz.si/files/uploaded/pr.prog.ceplj_2021.pdfPravilnik o določitvi Programa cepljenja in zaščite z zdravili za leto2021Accessed January 26 th, 2022 athttps://www.nijz.si/sites/www.nijz.si/files/uploaded/pr.prog.ceplj_2021.pdfSearch in Google Scholar
Official gazette of Rupublic of Slovenia. Pravilnik o cepljenju, zaščiti z zdravili in varstvu pred vnosom in razširjenjem nalezljivih bolezni. Accessed March 7th, 2021 at: https://www.uradni-list.si/1/content?id=18410Official gazette of Rupublic of SloveniaPravilnik o cepljenju, zaščiti z zdravili in varstvu pred vnosom in razširjenjem nalezljivih bolezni. Accessed March 7th2021https://www.uradni-list.si/1/content?id=18410Search in Google Scholar
Seme K, Komloš Fujs K, Poljak M. Screening of pregnant women for hepatitis B virus infection. Med Razgl. 2006;45(Suppl3):123-6. Slovenian.SemeKKomlošFujs KPoljakMScreening of pregnant women for hepatitis B virus infectionMed Razgl200645Suppl31236SlovenianSearch in Google Scholar
ECDC. Antenatal screening for HIV, hepatitis B, syphilis and rubella susceptibility in the EU/EEA – addressing the vulnerable populations. 2017. Accessed March 7th, 2021 at: https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/antenatal-screening-sci-advice-2017.pdfECDC. Antenatal screening for HIV, hepatitis B, syphilis and rubella susceptibility in the EU/EEA – addressing the vulnerable populations. 2017Accessed March 7th, 2021 athttps://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/antenatal-screening-sci-advice-2017.pdfSearch in Google Scholar
Collins English Dictionary. Origin. Accessed Juanuary 27th, 2022 at: https://www.collinsdictionary.com/dictionary/english/originCollins English DictionaryOrigin. Accessed Juanuary 27th2022https://www.collinsdictionary.com/dictionary/english/originSearch in Google Scholar
EASL. EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67:370-98. doi: 10.1016/j.jhep.2017.03.021EASLEASL 2017 clinical practice guidelines on the management of hepatitis B virus infectionJ Hepatol2017673709810.1016/j.jhep.2017.03.02128427875Open DOISearch in Google Scholar
Grasselli Kmet N, Poljak M, Rajter M, Selič T, Baklan Z, Pal E et al. Vaccination in the Yugoslav National Army: a significant risk factor for acquiring chronic hepatitis B virus infection during army service in former Yugoslavia. J Arch Mil Med 2020;8(4):e111950. Doi: 10.5812/jamm.111950.GrasselliKmet NPoljakMRajterMSeličTBaklanZPalEet alVaccination in the Yugoslav National Army: a significant risk factor for acquiring chronic hepatitis B virus infection during army service in former YugoslaviaJ Arch Mil Med202084e11195010.5812/jamm.111950Open DOISearch in Google Scholar
ECDC. Systematic review on hepatitis B and C prevalence in the EU/ EEA. 2016. Accessed March 7th, 2021 at: https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/systematic-review-hepatitis-B-C-prevalence.pdfECDC. Systematic review on hepatitis B and C prevalence in the EU/ EEA. 2016Accessed March 7th, 2021 athttps://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/systematic-review-hepatitis-B-C-prevalence.pdfSearch in Google Scholar
Van Damme P, Leuridan E, Hendrickx G, Vorsters A, Theeten H, Leino T, et al. Should Europe have universal hepatitis B vaccination programme? BMJ. 2013;346:f4057. doi:10.1136/bmj.f4057.VanDamme PLeuridanEHendrickxGVorstersATheetenHLeinoTet alShould Europe have universal hepatitis B vaccination programme?BMJ2013346f405710.1136/bmj.f405723843546Open DOISearch in Google Scholar
WHO. Prevention of mother-to-child transmission of hepatitis B virus: guidelines onantiviral prophylaxis in pregnancy. 2020. Accessed March 7th, 2021 at: https://apps.who.int/iris/bitstream/handle/10665/333391/9789240002708-eng.pdf?sequence=1&isAllowed=yWHO. Prevention of mother-to-child transmission of hepatitis B virus: guidelines onantiviral prophylaxis in pregnancy. 2020Accessed March 7th, 2021 athttps://apps.who.int/iris/bitstream/handle/10665/333391/9789240002708-eng.pdf?sequence=1&isAllowed=ySearch in Google Scholar
Kojouharova M, Kurchatova A. Bulgaria: Impact of the universal newborn HBV vaccination programme: 20 years after. Viral hepatitis prevention board meeting. Milan, Italy, November 17-18, 2011. Accessed March 7th, 2021 at: http://www.vhpb.org/files/html/Meetings_and_publications/Presentations/MILS45.pdfKojouharovaMKurchatovaABulgaria: Impact of the universal newborn HBV vaccination programme: 20 years after. Viral hepatitis prevention board meetingMilan, ItalyNovember 17-182011Accessed March 7th, 2021 athttp://www.vhpb.org/files/html/Meetings_and_publications/Presentations/MILS45.pdfSearch in Google Scholar
Ni YH, Huang LM, Chang MH, Yen CJ, Lu CY, You SL, et al. Two decades of universal hepatitis B vaccination in Taiwan: impact and implication for future strategies. Gastroenterology. 2007;132:1287–93. doi: 10.1053/j.gastro.2007.02.055.NiYHHuangLMChangMHYenCJLuCYYouSLet alTwo decades of universal hepatitis B vaccination in Taiwan: impact and implication for future strategiesGastroenterology200713212879310.1053/j.gastro.2007.02.05517433322Open DOISearch in Google Scholar
Liu J, Liang W, Jing W, Liu M. Countdown to 2030: eliminating hepatitis B disease, China. 2019. Accessed March 7th, 2021 at: https://www.who.int/bulletin/volumes/97/3/18-219469/en/LiuJLiangWJingWLiuMCountdown to 2030: eliminating hepatitis B disease, China2019Accessed March 7th, 2021 athttps://www.who.int/bulletin/volumes/97/3/18-219469/en/10.2471/BLT.18.219469645331130992636Search in Google Scholar
Chen DS. Hepatitis B vaccination: The key toward elimination and eradication of hepatitis B. J Hepatol. 2009;50:805-16. doi: 10.1016/j.jhep.2009.01.002.ChenDSHepatitis B vaccination: The key toward elimination and eradication of hepatitis BJ Hepatol2009508051610.1016/j.jhep.2009.01.00219231008Open DOISearch in Google Scholar
Hadziyannis SJ. Natural history of chronic hepatitis B in Euro-Mediterranean and African countries. J Hepatol. 2011;55:183-91. doi: 10.1016/j.jhep.2010.12.030.HadziyannisSJNatural history of chronic hepatitis B in Euro-Mediterranean and African countriesJ Hepatol2011551839110.1016/j.jhep.2010.12.03021238520Open DOISearch in Google Scholar
Wu JF, Chang MH. Natural history of chronic hepatitis B virus infection from infancy to adult life – the mechanism of inflammation triggering and long-term impacts. J Biomed Sci. 2015;22:92-116. doi: 10.1186/s12929-015-0199-y.WuJFChangMHNatural history of chronic hepatitis B virus infection from infancy to adult life – the mechanism of inflammation triggering and long-term impactsJ Biomed Sci2015229211610.1186/s12929-015-0199-y461823526487087Open DOISearch in Google Scholar